Former FDA Commissioner to Join J&J Board and 2 Other Dow Movers to Watch
Johnson & Johnson (NYSE:JNJ): Current price $89.27
J&J announced Monday that Mark B. McClellan, M.D., Ph.D., Senior Fellow in Economic Studies, and Director of the Initiative on Value and Innovation in Health Care, Brookings Institution will join its Board of Directors on Tuesday. McClellan will serve on the Regulatory, Compliance & Government Affairs Committee and the Science, Technology & Sustainability Committee of the Board. He was the former commissioner of the FDA from 2002 to 2004, and the former administrator of the Centers for Medicare & Medicaid Services for the United States Department of Health and Human Services from 2004 to 2006.